Key result
Intravenous esmolol infusion significantly reduced the time to regain full orientation (7.33 vs 25.00 minutes) compared to control in patients undergoing elective plastic surgery.
Why the study?
The study aimed to investigate the cardiovascular effects of esmolol and the quality of emergence from anaesthesia in patients undergoing elective plastic surgery under general balanced anaesthesia.
Does esmolol infusion improve cardiovascular parameters and quality of postoperative recovery in patients scheduled for elective plastic surgery?
RCT (n=30)
Randomised in two groups
No
Does esmolol infusion improve cardiovascular parameters and quality of postoperative recovery in patients scheduled for elective plastic surgery?
Absolute Event Rate: 7.33% vs 25%
p-value: p=<0.01
Esmolol infusion during elective plastic surgery improves perioperative hemodynamics and facilitates faster, smoother emergence from anesthesia with reduced need for other anesthetic drugs.
Esmolol may stabilize hemodynamics and speed recovery in plastic surgery anesthesia; hypothesis-generating, larger trials needed before practice change.
Background/Aim: Esmolol is an ultra-short-acting, easily titratable b-adrenergic receptor antagonist used for urgent treatment of hypertension and tachycardia in non-surgical and surgical settings. Aim of this clinical study was to investigate its cardiovascular effects and quality of the emergence from anaesthesia in patients scheduled for elective plastic surgery under general balanced anaesthesia. Methods: A total of 30 ASA I/II patients were randomised in two groups of similar demographic characteristics and baseline values of cardiovascular parameters. Esmolol group received esmolol dissolved in glucose 5 % as an intravenous infusion, 0.3 mg/kg/min during the first 5 min and at a rate of 0.1 mg/kg/ min thereafter. Control patients received the solvent only, at the same rate and volume. General balanced anaesthesia was induced with thiopentone sodium and fentanyl and maintained with nitrous oxide and oxygen. Neuromuscular relaxation was assured with pancuronium bromide and was antagonised at the end of operation with atropine and neostigmine. Systolic and diastolic blood pressure and heart rate were registered at all critical phases: (1) immediately prior to the induction (baseline value), (2) induction to anaesthesia, (3) tracheal intubation, (4) first skin incision, (5) surgical manipulation with organs, (6) suture of the surgical wound and (7) tracheal extubation. Drug consumption and quality of postoperative recovery were monitored. Results: In most of the critical phases of anaesthesia and operation, patients from the Esmolol group had significantly lower values of cardiovascular parameters than the patients from the Control group. Esmolol-treated patients needed less fentanyl, droperidol and pancuronium and had faster and smoother emergence from anaesthesia than the control patients. Conclusion: Esmolol improved haemodynamics and post-anaesthesia recovery in patients undergoing elective plastic surgery under general balanced anaesthesia.
No takes yet. Share an insight, caveat, or question.
Dragana Lončar-Stojiljković (2021) conducted an RCT in Elective plastic surgery (n=30). Esmolol vs. Glucose 5% solution was evaluated on Time until regaining full orientation (minutes) (p=<0.01). Intravenous esmolol infusion significantly reduced the time to regain full orientation (7.33 vs 25.00 minutes) compared to control in patients undergoing elective plastic surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: